Smoking and smoking cessation in Latin America: A review of the current situation and available treatments

International Journal of COPD

Volumn 3, Issue 2, 2008, Pages 285-293

  Müller, Fernando ^a   Wehbe, Luis ^b  

^a Univ National de Buenos Aires and Proyecto Médico Especialista en Dejar de Fumar   (Argentina)

^b Ave Pulmo Somoking Cessation Institute ^*  (Argentina)

Author keywords

Latin America; Smoking; Smoking cessation; Tobacco

Indexed keywords

AMFEBUTAMONE; NICOTINE; NICOTINE GUM; NOSE SPRAY; PLACEBO; VARENICLINE;

ABNORMAL DREAMING; CARDIOVASCULAR DISEASE; CHRONIC OBSTRUCTIVE LUNG DISEASE; CLINICAL TRIAL; COUGHING; CULTURAL FACTOR; DISEASE PREDISPOSITION; DRUG COST; DRUG DOSE REGIMEN; DRUG INDUCED HEADACHE; ECONOMIC ASPECT; EDUCATION; GASTROINTESTINAL SYMPTOM; GOVERNMENT; HEALTH CARE COST; HEALTH CARE POLICY; HICCUP; HUMAN; INHALER; INSOMNIA; JAW DISEASE; JAW PAIN; MALIGNANT NEOPLASTIC DISEASE; MEDICAL EDUCATION; MOUTH BURNING; MOUTH DISEASE; MOUTH IRRITATION; NAUSEA; NERVOUSNESS; NICOTINE REPLACEMENT THERAPY; NOSE IRRITATION; PANDEMIC; POVERTY; RECOMMENDED DRUG DOSE; REIMBURSEMENT; REVIEW; RHINORRHEA; SIDE EFFECT; SKIN IRRITATION; SMOKING CESSATION; SOUTH AND CENTRAL AMERICA; TAX; THROAT BURNING; THROAT DISEASE; THROAT IRRITATION; TOBACCO DEPENDENCE; TREATMENT DURATION; XEROSTOMIA;

HUMANS; LATIN AMERICA; PREVALENCE; RISK FACTORS; SMOKING; SMOKING CESSATION;

EID: 47849087617     PISSN: 11769106     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (74)

1. Anon. 1989. Latin American Issue. Tobacco International, 6.
2. Anon. 2005a. Country market insight, Colombia. Euromonitor Internacional, 6-7.
3. Anon. 2005b. Estudio FuMABA (Fumar en Médicos Asistenciales de hospitales de Buenos Aires) Informe preliminar. Presented at 33 Congreso Asociación Argentina de Medicina Respiratoria. Mendoza, Argentina.
4. Anon. 2006a. Anuario del tabaco 2005, SAGyP [online]. Accessed 25 February 2007. URL: http://www.sagpya.mecon.gov.ar/scripts/ tab_prcia2.idc
5. The Agree Collaboration. 2001. AGREE Instrument Spanish version [online]. Accessed 8 July 2007. URL: http://www.agreecollaboration.org.
6. Bello S, Soto M, Michalland M, et al. 2004. Encuesta nacional de tabaquismo en funcionarios de salud. Rev Méd Chile, 134:223-32.
7. Biskobing DM. 2002. COPD and osteoporosis. Chest, 121:609-20.
8. Bruni JM. 2004. Ministerio de Salud y Ambiente de la Nación. Proyecto VIGIA. Informe final 2004. Costos Directos de la Atención Medica de las Enfermedades Atribuibles al Consumo de Tabaco en Argentina.
9. Cahill K, Stead L, Lancaster T. 2007. Nicotine receptor partial agonists for smoking cessation. Cochrane Database Syst Rev, CD006103.
10. Crofton J. 1990. Tobacco and the third world. Thorax, 45:164-9.
11. Department of Health and Human Services, Centers for Disease Control and Prevention. 2007. Global Youth Tobacco Survey. Country Reports: Pan American Health Organization [online]. Accessed 23 March 2007. URL: www.cdc.gov/tobacco/global/GYTS/reports/paho/reports.htm.
12. Ding A. 2005. Curbing adolescent smoking: a review of the effectiveness of various policies. Yale J Biol Med, 78:37-44.
13. Ding A. 2003. Youth are more sensitive to price changes in cigarettes than adults. Yale J Biol Med, 76:115-24.
14. Droguería Vida Bucaramanga de Colombia, Farmacia Soudriers de Uruguay, Farmacia Klein de Argentina [online]. Accessed 25 August 2007. URL: www.kairosweb.com
15. ERC Statistics International. 2004. The World Cigarette Market: The 2004 Survey. Suffolk, UK.
16. Ferrero F, Castaño C, Durán P, et al. 2004. Grupo de Estudio del Tabaquismo en la Residencia de Pediatría. Prevalencia del consumo de tabaco en médicos residentes de pediatría en Argentina. Rev Panam Salud Publica, 15:395-9.
17. Fish-Menezes M. 2006.The illegal market in Brazil. Presented at the first meeting of the WHO expert committee on the illicit tobacco trade. 2006. Geneva, Switzerland.
18. GlaxoSmithKline. 2007a. Smoking Cessation Resource Center [online]. Accessed 26 September 2007. URL: http://www.gsk-scrc.com/.
19. GlaxoSmithKline. 2007b. Zyban (bupropion hydrochloride) [US prescribing information]. Research Triangle Park, NC.
20. Granero R and Sanchez M. 2006. [Changes in tobacco use and related factors in Junior High School students, Lara State, Venezuela, 2000-2003]. Cad Saude Publica, 22:1893-9.
21. Harwood GA, Salsberry P, Ferketich AK, et al. 2007. Cigarette smoking, socioeconomic status, and psychosocial factors: examining a conceptual framework. Public Health Nurs, 24:361-71.
22. Hughes J, Stead L, Lancaster T. 2004. Antidepressants for smoking cessation. Cochrane Database Syst Rev, CD000031.
23. Huiart L, Ernst P, Suissa S. 2005. Cardiovascular morbidity and mortality in COPD. Chest, 128:2640-6.
24. Jacobson B, Amos A, Aghi M. 1989. World no tobacco day: a challenge for women's health. Lancet, 1:1193-4.
25. Joossens L, Raw M. 1998. Cigarette smuggling in Europe: who really benefits? Tob Control, 7:66-71.
26. Mackay J, Eriksen M, Shafey O. 2006. In Lacey C, King J, Mayne S (eds). The Tobacco Atlas. Atlanta, GA: American Cancer Society.
27. Medina E, Kaempffer AM. 1991. [Smoking and health in Chile]. Bol Oficina Sanit Panam, 111:112-21.
28. Minervini MC, Patiño C, Zabert G, et al. 1998. Smoking prevalence among Argentine physicians. AJRCC, 157:A504.
29. Minervini MC, Zabert GE, Rondelli MPP, et al. 2006. Tobacco use among Argentine physicians: personal behavior and attitudes. Revista Argentina de Medicina Respiratoria, 6:100-105.
30. Ministerio de salud-OPS. 2006. Indicadores Básicos 2006. [online]. Accessed 17 March 2007. URL: www.msal.gov.ar.
31. Ministerio de Salud y Ambiente de la Nación. 2005a. Guía Nacional de Tratamiento de la adicción al tabaco [online]. Accessed 8 April 2007. URL: www.msal.gov.ar.
32. Ministerio de Salud y Ambiente de la Nación. 2005b. Primera Encuesta Nacional de Factores de Riesgo [online]. Accessed 21 April 2007. URL: www.msal.gov.ar.
33. Mirra AP, Rosemberg J. 1997a. Inquérito sobre prevalência do tabagismo na classe médica brasileira. Rev Assoc Med Bras, 43:209-16.
34. Mirra AP, Rosemberg J. 1997b. [Survey on prevalence of smoking among Brazilian physicians]. Rev Assoc Med Bras, 43:209-16.
35. Misdorp S. 1990. Paraguay Report. Tobacco International, 36.
36. Molinari M. 2006. Legislación de Control de Tabaco. In F Müller (ed) Cesación Tabáquica: Tiempo de Intervenir. Buenos Aires, Argentina: Polemos Editorial.
37. Monreal LA, Tezoquipa IH, Jasso R, et al. 2004. Prevalencia de tabaquismo de médicos y enfermeras en los Estados de Morelos y Guanajuato. Rev Inst Nal Enf Resp Méx, 17:261-5.
38. Müller F, Zabert G. Prevalencia de Tabaquismo en profesionales de la salud mental. Presented at 33 Congreso Asociación Argentina de Medicina Respiratoria. 2005. Mendoza, Argentina.
39. NICE. 2007. Guidelines developments methods. Information for national collaborating centres and Guidelines Developers [online]. Accessed 8 July 2007. URL: www.nice.org.uk.
40. Haití: Developments Associates, Inc. 1991. Narcotics Awareness and Education Project. (NAE). National study of drug prevalence and attitudes towards drug use in Haití.
41. Noble M, Pérez-Stable E, Casal E. 1996. El comportamiento médico en relación al tabaquismo. Boletín de la Acad Nac de Medicina, 74:413-25
42. Organización Mundial de la Salud. 1999. Informe Sobre la Salud en el Mundo [online]. Accessed URL: www.who.int/whr/1999/en/ whr99_dgmessage_es.pdf.
43. Organización Panamericana de la Salud. 2003. Encuesta de Diabetes e Hipertensión y sus factores de Riesgo. Central American Diabetes Initiative (CAMDI).
44. Organización Panamericana de la Salud. 2000. La epidemia de tabaquismo: Los gobiernos y los aspectos económicos del control del tabaco [online]. Accessed 13 March 2007. URL: www.paho.org/spanish/ DBI/PC577/PC577_prelim.pdf.
45. Organización Panamericana de la Salud. 2005. Sistema Panamericano de Información en Línea de Tabaco (PATIOS) [online]. Accessed 20 April 2007. URL: http://www.paho.org/tobacco/ SpaPatiosHome.asp.
46. Pan American Health Organization [online]. Accessed 20 April 2007. URL: www.paho.org.
47. Pan American Health Organization. 2003. Comisión Salvadoreña Antidrogas. COSA. Information provided by WHO PAHO regional office.
48. Perez P, Wiesner C. 2004. Años perdidos de vida saludable por muerte prematura e incapacidad, asociados al consumo de cigarrillo en Colombia. Revista Colombiana de Cancerología, 8:21-27.
49. Pfizer, Inc. 2005a. Nicotrol Inhaler (nicotine inhalation system) [US prescribing information]. Morris Plains, NJ.
50. Pfizer, Inc. 2005b. Nicotrol NS (nicotine nasal spray) [US prescribing information]. Morris Plains, NJ.
51. Pfizer, Inc. 2007. Chantix (varenicline) [US prescribing information]. New York, NY.
52. Presidencia de la República Oriental del Uruguay. 2007. Edicion Completa de la Investigación Detenidos Desaparecidos [online]. Accessed 22 August 2007. URL: www.presidencia.gub.uy/_Web/noticias/2007/ 06/200706509.htm
53. Rondelli P, Zabert G, Minervini MC, et al. 1999. Physician's knowledge and attitude towards tobacco. AJRCC, 159:A487.
54. Sánchez P, Lisanti N. 2003. Prevalencia de tabaquismo y actitud hacia ese hábito entre médicos del Azuay, Ecuador. Rev Panam Salud Publica, 14:25-30.
55. Sansores RH, Ramírez-Venegas A, Espinosa-Martínez M, et al. 2002. Tratamientos para dejar de fumar, disponibles en México. Salud Publica Mex, 44:S116-24.
56. Sebrié EM, Barnoya J, Pérez-Stable EJ, et al. 2005. Tobacco industry successfully prevented tobacco control legislation in Argentina. Tob Control, 14:e2.
57. SEDRONAR. 1999. Encuesta nacional de sustancias psícoactivas [online]. Accessed 14 May 2007. URL: www.sedronar.gov.ar.
58. Shafey O, Dolwick S, Guindon GE. 2003. (eds) Tobacco Control Country Profiles 2003. Atlanta, GA: American Cancer Society.
59. Sidney S, Sorel M, Quesenberry CP Jr, et al. 2005. COPD and incident cardiovascular disease hospitalizations and mortality: Kaiser Permanente Medical Care Program. Chest, 128:2068-75.
60. Silagy C, Lancaster T, Stead L, et al. 2004. Nicotine replacement therapy for smoking cessation. Cochrane Database Syst Rev, CD000146.
61. US Department of Agriculture, Foreign Agricultural Service. 2004c. Tobacco: World Markets and Trade [online]. Accessed 11 April 2007. URL: http//www.fas.usda.gov/currwmt.html.
62. [USDH]. 1984. US Department of Health and Human Services, Public Health Service, Centers for Disease Control, Center for Chronic Disease Prevention and Health Promotion, Office of Smoking and Health. The Health Consequences of Smoking: Chronic Obstructive Lung Disease. DHS Publication No. (CDC) 84-50205.
63. [USDH]. 1986. US Department of Health and Human Services, Public Health Service, Centers for Disease Control, Center for Chronic Disease Prevention and Health Promotion, Office of Smoking and Health. The Health Consequences of Involuntary Smoking. DHS Publication No. (CDC) 87-8398.
64. [USDH]. 1990. US Department of Health and Human Services, Public Health Service, Centers for Disease Control, Center for Chronic Disease Prevention and Health Promotion, Office of Smoking and Health. The Health Benefits of Smoking Cessation. DHS Publication No. (CDC) 90-8146.
65. Valdés-Salgado R, Hernández-Ávila M and Sepúlveda-Amor J. 2002. El consumo de tabaco en la Región Americana: elementos para un programa de acción. Salud Pública México, 44:S125-S135.
66. Warren WW, Jones NR, Peruga A, et al. Global Youth Tobacco Surveillance, 2000-2007. MMWR, 57:1-21.
67. World Bank. 1999. Curbing the Epidemic: Governments and the Economics of Tobacco Control: Washington, DC.
68. [WHO] World Health Organization. 2002. The World Health Report: Reducing Risks, Promoting Healthy Life, Geneva.
69. [WHO] World Health Organization. 2007a. WHO Framework Convention on Tobacco Control (WHO FCTC) [online]. Accessed 21 April 2007. URL: http://www.who.int/tobacco/framework/en/.
70. [WHO] World Health Organization. 2007b. [online]. Accessed 27 September 2007. URL: http://www.who.int/topics/tobacco/en/.
71. Zabert G. 2006. Chapter 7: Los médicos y el tabaco. In FW Müller (ed) Cesación Tabáquica: Tiempo de Intervenir. Buenos Aires, Argentina: Editorial Polemos. 127-38.
72. Zabert G, Cecchini M, Rucci C, et al. Prevalencia de fumar en estudiantes de medicina de la UNComahue. Presented at AAMR. 2002.
73. Zabert G, Rondelli P, Minervini MC, et al. 1999. Smoking behavior in Argentine physicians. AJRCC, 159:A486.
74. Zabert G, Verra F. FUMAr. (Fumar en universitarios de medicina de Argentina). Presented at 32 Congreso Asociación Argentina de Medicina Respiratoria IV Congreso Asociación Latino-Americana del Tórax. 2004. Buenos Aires, Argentina.